微环境S100A8在急性髓系白血病进展与造血再生中的关键作用
研究发现急性髓系白血病中骨髓间充质干细胞的炎性细胞因子S100A8表达失调;体外上调S100A8促进白血病细胞增殖,而小鼠MLL-AF9白血病模型中去除间充质干细胞的S100A8可延长生存并减少白血病细胞浸润。S100A8结合白血病细胞Toll样受体4激活PI3K/Akt通路,并抑制间充质干细胞向成骨细胞分化、降低骨桥蛋白表达。
要点
- 急性髓系白血病中间充质干细胞的S100A8表达失调,体外上调S100A8促进白血病细胞增殖。
- 小鼠MLL-AF9白血病模型中去除间充质干细胞的S100A8可延长生存并减少白血病细胞浸润。
- 去除S100A8使造血干细胞数量暂时下降,但促进应激下的长期造血恢复。
核心结论
- 研究提示微环境炎症对促进急性髓系白血病发展并阻碍造血再生具有重要意义。
研究设计与样本
- 基础研究:以间充质干细胞为对象,在体外及小鼠MLL-AF9急性髓系白血病模型中研究S100A8的作用。
主要发现
- 急性髓系白血病中间充质干细胞的炎性细胞因子S100A8表达失调。
- 体外上调间充质干细胞的S100A8可增加白血病细胞增殖。
- 小鼠MLL-AF9白血病模型中去除间充质干细胞的S100A8导致生存期延长、白血病细胞浸润减少。
- S100A8结合白血病细胞上的Toll样受体4并激活PI3K/Akt通路。
- 去除间充质干细胞的S100A8使造血干细胞数量暂时下降,但促进应激下的长期造血恢复;S100A8抑制间充质干细胞向成骨细胞分化并降低支持造血干细胞所需的骨桥蛋白表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of inflammation in regulating acute myeloid leukemia (AML) and stressed hematopoiesis is significant, although the molecular mechanisms are not fully understood. Here, we found that mesenchymal stromal cells (MSCs) had dysregulated expression of the inflammatory cytokine S100A8 in AML. Upregulating S100A8 in MSCs increased the proliferation of AML cells in vitro. In contrast, removing S100A8 from MSCs in the murine MLL-AF9 AML model resulted in longer survival and less infiltration of leukemia cells. S100A8 binds to the Toll-like receptor 4 on leukemia cells, activating the PI3K/Akt pathway. In addition, removing S100A8 from MSCs caused a temporary decline in hematopoietic stem cell (HSCs) numbers, but facilitated long-term hematopoietic recovery under stress. Furthermore, S100A8 inhibited MSC differentiation into osteoblasts and reduced the expression of osteopontin, which is required for supporting HSCs. Our findings highlight the importance of niche inflammation in promoting AML development while impeding hematopoietic regeneration.
引用
- Liu X, Wu J, Li X, et al. Critical role of niche S100A8 for acute myeloid leukemia progression and hematopoiesis regeneration. Blood Adv. 2025. PMID: 40920990. doi:10.1182/bloodadvances.2024015762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。